Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis.
Assy
Nimer
N
Hussein
Osamah
O
Abassi
Zied
Z
D000328:Adult; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D005234:Fatty Liver / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D000077403:Orlistat; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects*
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat